Online Therapy for Depression
Trial Summary
What is the purpose of this trial?
This study is a randomized Type I hybrid effectiveness-implementation trial aimed at evaluating the effectiveness of Empower@Home, an internet-delivered cognitive-behavioral therapy (CBT) program supported by aging service providers, in comparison to enhanced usual care for homebound older adults with depressive symptoms. A total of 256 participants will be randomly assigned to either the treatment group (Empower@Home) or the control group (enhanced usual care) in a 1:1 allocation ratio, with randomization stratified by participating agencies. The primary aim of this study is to determine the clinical effectiveness of the Empower@Home program. It is hypothesized that participants receiving Empower@Home will show greater improvements in depressive symptoms at 12, 24, and 36 weeks after entering the study compared to those receiving enhanced usual care. Additionally, treatment moderators will be explored and a cost-effectiveness analysis will be conducted to assess the economic viability of the intervention. The second aim is to investigate the mechanisms of change facilitated by the intervention using a mixed-methods approach. Causal mediation analysis will examine whether the acquisition of CBT skills, reduction in cognitive distortions, and increased behavioral activation, as well as participant engagement and the therapeutic alliance with the coach, mediate the treatment effects. Qualitative interviews with participants will be conducted to provide deeper insights into these mechanisms and enhance the interpretation of the mediation analysis. The third aim focuses on evaluating the implementation process using the updated Consolidated Framework for Implementation Research (CFIR). This will involve a qualitative process evaluation to identify barriers and facilitators to the implementation of Empower@Home, drawing on perspectives from multiple stakeholders.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does require that if you are receiving outside therapy, you should not increase its frequency during the study.
What data supports the effectiveness of the treatment Empower@Home for depression?
Research shows that online cognitive-behavioral therapy (CBT) programs, similar to Empower@Home, can effectively reduce depression symptoms. Studies indicate that these programs, even without a live therapist, are highly usable and credible, and can significantly improve depressive symptoms over time.12345
How is the Empower@Home treatment for depression different from other treatments?
Empower@Home is unique because it delivers cognitive-behavioral therapy (CBT) over the Internet, allowing patients to receive therapy from home with supportive coaching, which can be as effective as traditional in-person therapy. This approach makes therapy more accessible, especially for those who cannot easily attend in-person sessions.24678
Research Team
Xiaoling Xiang
Principal Investigator
University of Michigan
Eligibility Criteria
This trial is for homebound older adults experiencing depressive symptoms. Participants should be willing to engage with an online cognitive-behavioral therapy program or receive enhanced usual care through telephone visits. Specific eligibility criteria are not provided, but typically these would include age thresholds and a clinical diagnosis of depression.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Empower@Home program, a 9-session online CBT intervention with support from aging service providers
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Empower@Home
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
NYU Silver School of Social Work
Collaborator